The Recall Desk
HighFDA (Devices)·Z-0107-2018·Announced 2017-11-29

Medtronic MiniMed Quick-set Infusion Sets Recalled for Insulin Over-delivery Risk

Medtronic is recalling MiniMed Quick-set infusion sets because they may deliver too much insulin. The recall covers 3,971,030 units distributed worldwide.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a risk of harm (insulin over-delivery) without reported injuries or illnesses in the source text, which aligns with the 'High' severity criteria.

Plain-English summary

Medtronic Inc. is recalling Medtronic MiniMed(TM) Quick-set(TM) infusion sets (models MMT-394, 394T, 399, 399T, 387, 387T, 398, 398T, 397, 397T, 386, 386T, 396, 396T). The recall involves 3,971,030 units that were distributed worldwide.

The recall is being conducted because the infusion sets have the potential for over-delivery of insulin. This hazard could result in patients receiving more insulin than prescribed.

Consumers and healthcare providers should check their infusion sets against the specific lot numbers listed in the official recall notice. If a set is affected, users should stop using it and contact Medtronic or their healthcare provider for instructions on replacement or further action.

The recalled product

Product
Medtronic MiniMed(TM) Quick-set(TM) (MMT-394, 394T, 399, 399T, 387, 387T, 398, 398T, 397, 397T, 386, 386T, 396, 396T)
Manufacturer
Medtronic Inc.
Affected units
3,971,030

Distribution

Distribution scope not specified by the agency.

Part of a larger recall action

This product is one of 5 recalled by Medtronic Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 5 products in this recall →